Form 4: NHC CEO Exercises Stock Options, Boosts Stake

Sentiment:

Insider Transaction Report 16 March 2026 4:10 PM

📋All filings for National Healthcare CORP

National Healthcare Corp CEO Stephen Flatt exercised options to acquire 1,853 shares of common stock at $53.94 per share.

Summary

Stephen Flatt, CEO and Director of National Healthcare Corp (NHC), acquired 1,853 shares of common stock.
The acquisition occurred on March 12, 2026, through the exercise of stock options at a price of $53.94 per share.
These options were granted on March 8, 2023, under the 2020 Omnibus Equity Incentive Plan.
Following this transaction, Flatt directly beneficially owns 65,505 shares of common stock.
Flatt also holds additional unexercised options for 10,000 shares (exercise price $94.1), 13,000 shares (exercise price $90.62), and 20,000 shares (exercise price $157.13).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as the CEO's decision to exercise options and increase direct share ownership typically indicates confidence in the company's future performance and aligns executive interests with shareholders.

Positives

The CEO's exercise of stock options increases his direct ownership in the company, aligning his interests further with shareholders.
The exercise price of $53.94 is likely below the current market price, indicating a profitable transaction for the insider and potential confidence in the stock's value.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider transaction.

Industry Context

StockSavvy.ai notes that insider transactions, such as option exercises by a CEO, are common occurrences in publicly traded companies. They often reflect an executive's compensation structure and can signal confidence in the company's long-term prospects, especially when the exercise price is below the current market value, indicating a profitable transaction for the insider.

Comparison to Industry Standards

The exercise of stock options by a CEO is a standard component of executive compensation packages across various industries, including healthcare. Companies like HCA Healthcare (HCA) and Universal Health Services (UHS) also utilize equity incentive plans to align executive interests with shareholder value, with similar Form 4 filings regularly disclosing such transactions.
The specific terms of the options, such as the exercise price of $53.94 and the grant date of March 8, 2023, are typical for long-term incentive awards designed to vest over several years.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Equity Incentive Plan	The stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan, which governs equity awards for company executives.	03/08/2023	Reinforces the company's existing executive compensation structure designed to align management incentives with shareholder value.

Stakeholder Impact

Shareholders: Increased alignment of CEO's interests with shareholders due to higher direct ownership.
Employees: No direct impact on general employees, but reflects the company's executive compensation practices.

Next Steps

Stephen Flatt continues to hold additional unexercised stock options with various exercise prices and expiration dates, which may be exercised in the future.

Key Dates

Date	Description
03/08/2023	Grant date of the stock options exercised.
03/08/2024	Date the exercised stock options became exercisable.
03/05/2025	Date another block of options (10,000 shares at $94.1) becomes exercisable.
02/28/2026	Date another block of options (13,000 shares at $90.62) becomes exercisable.
03/12/2026	Date of the stock option exercise transaction.
03/16/2026	Date the Form 4 was signed by Stephen Flatt.
02/23/2027	Date another block of options (20,000 shares at $157.13) becomes exercisable.
03/08/2028	Expiration date of the exercised stock options.
03/05/2029	Expiration date of options for 10,000 shares at $94.1.
02/28/2030	Expiration date of options for 13,000 shares at $90.62.
02/23/2031	Expiration date of options for 20,000 shares at $157.13.

Recommendation

hold

This Form 4 filing reports a routine insider transaction (option exercise) by the CEO. While it indicates the CEO's confidence and increased personal stake, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard compensation event.

Keywords

National Healthcare Corp, NHC, Stephen Flatt, Insider Transaction, Form 4, Stock Options, CEO, Equity Incentive Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.